Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Pharm Biomed Anal. 2012 Sep 5;72:245–250. doi: 10.1016/j.jpba.2012.08.029

Table 2.

Accuracy and precision (RSD) for assay of oseltamivir (OS) and oseltamivir oseltamivir carboxylate (OSC) in human plasma

Nominal
concentration
(ng/mL)
Within-run (n = 3) Between-run (n = 3)

Measured concentration (ng/mL)
mean ± SD (RSD)
Accuracy Measured concentration (ng/mL)
mean ± SD (RSD)
Accuracy
OS
0.34 (LLOQ) 0.33 ! 0.04 (11.0%) 97% 0.36 ! 0.04 (9.9%) 106%
4.1 3.90 ! 0.09 (2.2%) 95% 3.93 ± 0.07 (1.8%) 96%
37.1 37.1 ! 1.0 (2.7%) 100% 37.1 ± 0.8 (2.2%) 100%
333 339 ! 9 (2.5%) 102% 336 ± 8 (2.5%) 101%
OSC
0.34 (LLOQ) 0.36 ! 0.03 (9.7%) 104% 0.37 ! 0.03 (7.7%) 110%
4.1 4.04 ! 0.15 (3.7%) 98% 4.11 ± 0.14 (3.4%) 100%
37.1 37.5 ! 1.0 (2.6%) 101% 37.3 ± 0.8 (2.2%) 101%
333 339 ± 10 (3.0%) 102% 336 ± 8 (2.4%) 101%

The human plasma was treated with sodium fluoride before use.